AST has been demonstrated to reduce the mRNA expression levels of c-Myc and glycolytic enzymes (LDH-A, Glut-1, and HK2) in a DSS-induced mouse model, suggesting its potential for combating tumor-associated inflammation and maintaining normal glucose homeostasis [152]. Here, HK2 is linked to neoplasm.